Citi Pharma Limited (PSX:CPHL)
Pakistan
· Delayed Price · Currency is PKR 86.48
+0.09 (0.10%)
At close: Jun 5, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 19.76 billion as of June 6, 2025. Its market cap has increased by 174.10% in one year.
Market Cap
19.76B
Enterprise Value
21.38B
Revenue
12.97B
Ranking
n/a
PE Ratio
23.77
Stock Price
86.48
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 19.76B, an increase of 176.53%. That is a compound annual growth rate of 29.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 19.76B | 26.97% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 120.22B |
| Abbott Laboratories (Pakistan) | 91.99B |
| AGP Limited | 52.67B |
| Highnoon Laboratories | 47.36B |
| The Searle Company | 45.98B |
| Shifa International Hospitals | 29.47B |
| Ferozsons Laboratories | 15.49B |
| Otsuka Pakistan | 4.62B |